Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -3.44% | +40.00% | +7.46% | -12.77% | +12120.16% |
| Gross Profit Growth | +8.94% | +60.94% | +7.63% | -11.64% | +15728.72% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +6.39% | +6.87% | +7.24% | +2.05% | +0.86% |
| Weighted Average Shares Diluted Growth | +6.39% | +6.87% | +7.24% | +2.05% | +0.86% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -7.07% | +32.84% | +3.75% | -54.78% | +3.26% |
| Inventory Growth | +18.49% | +17.39% | +164.29% | +55.98% | +79.19% |
| Asset Growth | -20.00% | -28.53% | -40.84% | +39.15% | +50.78% |
| Book Value per Share Growth | -54.47% | -72.42% | -99.38% | -7.27% | +90.65% |
| Debt Growth | +879.79% | +912.56% | +1026.31% | +772.42% | +96.24% |
| R&D Expense Growth | +28.90% | +47.96% | +24.51% | +20.97% | +53.34% |
| SG&A Expenses Growth | +42.23% | +7.56% | -3.14% | +25.27% | +23.52% |